Sofia Greene [subject #1], Migraine Art 3, 2005. © 2005 Sofia Greene [more]
The outcome of the episodes of persistent aura without infarction was rated as complete remission (CR), partial remission (PR), stable disease (SD) and progressive disease (PD), respectively.
As a single episode of persistent aura can comprise multiple persisting symptoms that may differ in their time course of improvement, stability or worsening, these four categories of outcome need further definition.
To be coded as an episode with complete remission, all persistent symptoms that had occurred or significantly worsened during this episode must have fully remitted or returned to baseline severity. To be coded as an episode with partial remission, at least one of the symptoms that had occurred or significantly worsened during this episode must have improved and none of the symptoms must have progressively worsened over the entire duration of the episode. To be coded as an episode presenting as stable disease, all symptoms that had occurred or significantly worsened during this episode must retain the maximum intensity achieved during the episode and none of them must show a remission, an improvement, a return to baseline intensity or a worsening. Finally, to be coded as an episode presenting as progressive disease, at least one of the symptoms that had occurred or significantly worsened during this episode must have progressively worsened over the entire duration of the episode.
Only 45,8 % of all 166 episodes, sustained by 60 subjects with a diagnosis of definite persistent aura without infarction, show a complete or partial remission, which was in most cases a large remission, whereas in 51,2 % of the episodes one encounters a stable and in 3,0 % a progressive disease. As these rates include the data of a single subject (#175) with 29 episodes of persistent aura fully remitting each time, separate calculations were also made for the 60 first episodes and the 106 further episodes from the 60 subjects. Only 25,0 % of the 52 subjects' first episodes of persistent aura display a complete or large partial remission, whereas 71,7 % of the first episodes show a stable and 3,3 % a progressive disease.
Tobias [subject #418], Onset of 4th episode of persistent migraine aura with flickering in the entire visual field, August 14, 2007. © 2007 Tobias [more]
Tobias [subject #418], Partial remission of 4th episode of persistent migraine aura with flickering in the entire visual field, September 5, 2007. © 2007 Tobias [more]
In none of the 40 episodes with complete remission, but in 3 of the 36 episodes with partial remission, the improvement was attributed to the effect of pharmacotherapy.
In one of these observations, the reported pattern of drug administration mimicked a single-case experimental A-B-A-B design. The A-B-A-B design represents an attempt to measure a baseline (the first A), a treatment measurement (the first B), the withdrawal of treatment (the second A), and the re-introduction of treatment (the second B). Thus, after two years of progressive worsening ("unfortunately, many visuals slowly developed ... The thing is worsening: longer afterimage, and more shimmering, night vision is getting worse"), a treatment with Deanxit (a combination of the antidepressive agent melitracene and the neuroleptic drug flupentixole) brought a partial remission of Tadpolefighter's (subject's #8) persistent symptoms over the next four years. "I am very sure the improvement is directly due to the medication. I had tried a few times to stop Deanxit, but after a few days, I would noticed the after-image become more obvious and last longer. Same to the flickering and vibration. Once I continued the medication again, the visual improved."
(Tadpolefighter [subject #8], Ezboard forum Visual snow or static – Discussion - Visual due to depression?, December 11, 2002)
After three months' standing of the visual disturbances of Sheri's (subject's #86) 1st episode of persistent aura, a treatment with Verapamil "reduced the visuals" within a week "and almost eliminated the headaches".
(Sheri [subject #86], Ezboard Forum Visual snow or static - Discussion - Persistent migraine aura, February 18, 2006)
After having suffered from the repetitive variety of persistent aura without infarction with stereotyped daily attacks of expanding fortification spectra for 10 months, SF (subject #85) convinced his neurologist to prescribe a pharmacotherapy with valproic acid (Rothrock, 1997). On 2 months follow-up, SF reported: "I am very pleased to inform you that since I started taking the Sodium Valproate (Depakine Chrono 300) my aura symptoms have diminished dramatically. They have not gone entirely, but the change has been dramatic. It seems that the symptoms only return when I am very tired or stressed. I have attached my diary which I am still keeping. The diary clearly shows the reduction in symptoms. Thank you very much for your help. I will keep you informed of my progress."
(SF [subject #85], Email to Klaus Podoll, February 11, 2007)
The episodes of persistent aura without infarction showing a continuous progressive disease course may actually represent a sequence of discrete "micro-episodes" (not fulfilling the defined criteria of a distinct "episode" of persistent aura) brought on by recurrent attacks of migraine with aura, as suggested by the four following posts from email correspondence and internet forums devoted to visual snow.
Wang et al. (2008) published a systematic analysis of 29 patients (23 from the literature and 6 own) in terms of demographics, headache and visual symptom profiles, treatment regimens and outcomes. Even though the majority of patients had headache improvement, only 8 had complete resolution of persistent aura symptoms, without definite relevance to any specific agent. Patients with complete resolution of persistent aura symptoms tended to have scotoma, unilateral/homonymous involvement of visual symptoms, a higher number of symptoms more typical of migraine visual aura and a shorter duration of illness compared with those without. In conclusion, the prognosis of persistent aura was poor, and a higher number of symptoms more typical of migraine visual aura predicted a better outcome. For those with a potential for complete resolution, improvement would occur early in the course.
Peatfield et al. (2009) sought to assess the prognosis of persistent aura without infarction on the basis of a retrospective case series of 15 patients with symptoms lasting a minimum of 2 months, without permanent physical signs or CT or MRI scan abnormalities. These were collected from the case records of the Princess Margaret Migraine Clinic, Charing Cross Hospital, from 1980 to 2009. The authors reviewed the records and saw or telephoned the patients when necessary, to obtain an updated diagnosis. The persistent aura symptoms included blurring and shimmering of vision, with wiggly, twig-like or zigzag lines, persistent afterimages, and weakness of one leg with speech arrest. Headache was never a significant problem. The symptoms in 4 of the patients had resolved after a mean of 7 months. Another 4 were lost to follow-up, and the symptoms in the remaining 7 were continuing for between 2 months and 10,5 years. Thus, about a quarter (26,7%) of the patients completely remitted spontaneously within a few months and the remainder seem to continue indefinitely. None of the patients came to any long-term harm.
Peatfield R, Weatherall M, Mehta A, Waldman A. The prognosis of persistent migrainous aura. Cephalalgia 2009; 29 (Suppl. 1): 129.
Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology 1997; 48: 261-262.
Wang YF, Fuh JL, Chen WT, Wang SJ. The visual aura rating scale as an outcome predictor for persistent visual aura without infarction. Cephalalgia 2008; 28:1298-1304.
MIGRAINE CLASSIFICATION
|
MIGRAINE HEADACHE
|
MIGRAINE AURA
|
MIGRAINE ART
About Us |
Contact |
IMPRINT |
Sitemap
Copyright © 2006 Migraine Aura Foundation, All rights reserved.
Thanks to: RAFFELT MEDIENDESIGN and toms-projekte.de | webmaster@migraine-aura.org